Viatris

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
Reuters
Mon, 04/1/24 - 12:04 pm
Teva Pharmaceutical
JNJ
Viatris
schizophrenia
patents
Invega Sustenna
Viatris' launch plans scuttled as FDA rebuffs long-acting MS drug from partner Mapi
Fierce Pharma
Mon, 03/11/24 - 11:32 am
Viatris
FDA
Mapi Pharma
MS
multiple sclerosis
glatiramer acetate depot
Viatris splashes out $350m on pair of Idorsia therapies
Pharmaphorum
Wed, 02/28/24 - 10:45 am
Viatris
Idorsia
lupus
myocardial infarction
selatogrel
cenerimod
DOJ dismisses insider trading charges against Viatris official
Fierce Pharma
Tue, 01/30/24 - 09:20 pm
DOJ
Viatris
insider trading
legal
5 FDA Decisions to Watch in Q1
BioSpace
Tue, 01/2/24 - 11:24 am
FDA
Iovance Biotherapeutics
melanoma
lifileucel
Minerva Neurosciences
schizophrenia
roluperidone
Viatris
Mapi Pharma
MS
multiple sclerosis
GA Depot
Madrigal Pharmaceuticals
NASH
resmetirom
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
beta thalassemia
Regeneron Gains After Eye-Drug Patent Victory Over Viatris
Yahoo/Bloomberg
Sun, 12/31/23 - 11:46 am
Regeneron
Eylea
Viatris
patents
legal
Viatris and Theravance report data from COPD treatment trial
Clinical Trials Arena
Tue, 11/14/23 - 09:24 am
Viatris
Theravance
clinical trials
Yupelri
COPD
Viatris Just Sold Off 3 Key Segments. Is It Still a Buy?
Motley Fool
Fri, 10/13/23 - 10:10 am
Viatris
APIs
Women's Health
OTC
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
Fierce Pharma
Thu, 10/5/23 - 10:21 am
Viatris
generics
Novo Nordisk
Ozempic
Wegovy
diabetes
patents
USPTO
Viatris sells off consumer, women’s health drugs in asset sales
BioPharma Dive
Mon, 10/2/23 - 06:31 pm
Viatris
Women's Health
consumer health
FDA Approves Viatris, Ocuphire’s Eye Drops to Reverse Pupil Dilation
BioSpace
Thu, 09/28/23 - 10:11 am
Viatris
Ocuphire
Ryzumvi
mydriasis
FDA grants tentative approval for Viatris’ pediatric HIV drug
Business Today
Tue, 09/5/23 - 08:53 pm
Viatris
FDA
HIV
pediatrics
abacavir
dolutegravir/lamivudine
In win for generics industry, Viatris wards off $50M payment in tax battle with IRS
Fierce Pharma
Mon, 07/31/23 - 10:06 pm
Viatris
IRS
taxes
patents
generics
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
BioSpace
Wed, 06/7/23 - 11:22 am
biosimilars
biologics
drug pricing
Roche
Herceptin
Amgen
Kanjinti
Viatris
Ogivri
Pfizer
Trazimera
Teva Pharmaceutical
Herzuma
Organon
Ontruzant
J&J beats back Viatris' generic challenge to schizophrenia med Invega Trinza
Fierce Pharma
Thu, 05/18/23 - 11:16 am
JNJ
schizophrenia
generics
Trinza
Viatris
Double whammy: Supreme Court slaps down separate bids from Novartis, Sanofi
Fierce Pharma
Tue, 04/18/23 - 09:58 am
legal
Supreme Court
Novartis
Gilenya
Sanofi
Viatris
EpiPens
Viatris maintains legal winning streak with yet another EpiPen antitrust victory
Fierce Pharma
Mon, 04/3/23 - 10:51 pm
Viatris
EpiPen
Mylan
legal
antitrust
Mer­ck, Vi­a­tris agree to set­tle patent feud sur­round­ing di­a­betes drugs
Endpoints
Mon, 03/20/23 - 04:30 pm
Merck
Viatris
patents
diabetes
Januvia
Janumet
US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case
Endpoints
Mon, 02/13/23 - 10:12 pm
Pfizer
Viatris
Sanofi
Regeneron
patents
Supreme Court
FDA rejects Biocon and Viatris' Avastin biosimilar after inspection question marks
Endpoints
Mon, 02/13/23 - 10:02 pm
FDA
Biocon
Viatris
Avastin
biosimilars
drug manufacturing

Pages